Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Journal of Translational Medicine
|
September 13, 2024
Repeated prefrontal tDCS for improving mental health and cognitive deficits in multiple sclerosis: a randomized, double-blind, parallel-group study
Nasim Zakibakhsh, Sajjad Basharpoor, Hamidreza Ghalyanchi Langroodi, et al.
Basic and Clinical Neuroscience
|
July 29, 2024
Brain MRI Volumetric Assessment of Patients With Multiple Sclerosis: The Volume of Basal Ganglia, Thalamus, and Posterior Fossa
Sima Fallah Arzpeyma, Sara Janeshin, Niusheh Soofi Afshar, et al.
Acta Neurologica Belgica
|
June 17, 2016
Neuromyelitis optica and pregnancy
Ameneh Zare-Shahabadi, Hamidreza Ghalyanchi Langroodi, Amir Reza Azimi, et al.
Multiple Sclerosis and Related Disorders
|
September 1, 2024
Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY)
Vahid Shaygannejad, Fereshteh Ashtari, Morteza Saeidi, et al.
Multiple Sclerosis and Related Disorders
|
December 13, 2021
Characteristics of COVID-19 in patients with multiple sclerosis
Fereshteh Ghadiri, Mohammad Ali Sahraian, Vahid Shaygannejad, et al.
Multiple Sclerosis and Related Disorders
|
November 17, 2017
Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations
Mohammad Ali Sahraian, Abdorreza Naser Moghadasi, Amir Reza Azimi, et al.
Scientific Reports
|
October 22, 2024
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial
Mohammad Ali Sahraian, Roya Abolfazli, Vahid Shaygannejad, et al.
Current Journal of Neurology
|
November 27, 2023
Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment
Fereshteh Ghadiri, Elnaz Asadollahzadeh, Zahra Ebadi, et al.
Current Journal of Neurology
|
November 27, 2023
Iranian specialists' approach to surgery in patients with multiple sclerosis
Fereshteh Ghadiri, Zahra Ebadi, Elnaz Asadollahzadeh, et al.
Multiple Sclerosis and Related Disorders
|
November 20, 2025
Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS -infectious disease group
Sepideh Paybast, Marzie Abutorabi-Zarchi, Fereshteh Ashtari, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Journal of Translational Medicine
|
September 13, 2024
Repeated prefrontal tDCS for improving mental health and cognitive deficits in multiple sclerosis: a randomized, double-blind, parallel-group study
Nasim Zakibakhsh, Sajjad Basharpoor, Hamidreza Ghalyanchi Langroodi, et al.
Basic and Clinical Neuroscience
|
July 29, 2024
Brain MRI Volumetric Assessment of Patients With Multiple Sclerosis: The Volume of Basal Ganglia, Thalamus, and Posterior Fossa
Sima Fallah Arzpeyma, Sara Janeshin, Niusheh Soofi Afshar, et al.
Acta Neurologica Belgica
|
June 17, 2016
Neuromyelitis optica and pregnancy
Ameneh Zare-Shahabadi, Hamidreza Ghalyanchi Langroodi, Amir Reza Azimi, et al.
Multiple Sclerosis and Related Disorders
|
September 1, 2024
Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY)
Vahid Shaygannejad, Fereshteh Ashtari, Morteza Saeidi, et al.
Multiple Sclerosis and Related Disorders
|
December 13, 2021
Characteristics of COVID-19 in patients with multiple sclerosis
Fereshteh Ghadiri, Mohammad Ali Sahraian, Vahid Shaygannejad, et al.
Multiple Sclerosis and Related Disorders
|
November 17, 2017
Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations
Mohammad Ali Sahraian, Abdorreza Naser Moghadasi, Amir Reza Azimi, et al.
Scientific Reports
|
October 22, 2024
Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial
Mohammad Ali Sahraian, Roya Abolfazli, Vahid Shaygannejad, et al.
Current Journal of Neurology
|
November 27, 2023
Iranian specialists' approach to treatment escalation in multiple sclerosis patients with cognitive impairment
Fereshteh Ghadiri, Elnaz Asadollahzadeh, Zahra Ebadi, et al.
Current Journal of Neurology
|
November 27, 2023
Iranian specialists' approach to surgery in patients with multiple sclerosis
Fereshteh Ghadiri, Zahra Ebadi, Elnaz Asadollahzadeh, et al.
Multiple Sclerosis and Related Disorders
|
November 20, 2025
Infection screening prior to Ocrelizumb initiation in patients with Multiple Sclerosis (MS): Concise clinical recommendation based on a modified Delphi consensus on behalf of the Iranian MS -infectious disease group
Sepideh Paybast, Marzie Abutorabi-Zarchi, Fereshteh Ashtari, et al.
Page
of 2